ENAVO-TAVR: ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (clinicaltrials.gov) - Jun 30, 2026 - P4 | N=1040 | Recruiting | Sponsor: Duk-Woo Park, MD | Trial completion date: Apr 2027 ➔ Apr 2029 | Trial primary completion date: Dec 2026 ➔ Dec 2028
Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
|